TerminatedNCT03867435

Assessing Clinical Endpoints and Biomarkers in Myotonic Dystrophy Type-1 and Type 2 (ASCEND-DM)

Studying Proximal myotonic myopathy

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Principal Investigator
Ami K Mankodi, M.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Enrollment
4 enrolled
Eligibility
11-70 years · All sexes
Timeline
20202021

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03867435 on ClinicalTrials.gov

Other trials for Proximal myotonic myopathy

Additional recruiting or active studies for the same condition.

See all trials for Proximal myotonic myopathy

← Back to all trials